| BASD | Bile acid synthesis disorders |
| HSD-469 | 3β-sulfooxy-7α-hydroxy-chol-5-en-24-oic acid |
| HSD-485 | 3β-sulfooxy-7α,12α-dihydroxy-chol-5-en-24-oic acid |
| HSD-526 | Glycine conjugate of 3β-sulfooxy-7α-hydroxy-chol-5-en-24-oic acid |
| HSD-542 | Glycine conjugate of 3β-sulfooxy-7α,12α-dihydroxy-chol-5-en-24-oic acid |
| HSD-469-IS | [2,3,3,23,23-2H5]3β-sulfooxy-7α-hydroxy-chol-5-en-24-oic acid |
| HSD-485-IS | [2,3,3,23,23-2H5]3β-sulfooxy-7α,12α-dihydroxy-chol-5-en-24-oic acid |
| HSD-526-IS | [1,2-13C2, 2,2-2H2,3-15N]glycine conjugate of 3β-sulfooxy-7α-hydroxy-chol-5-en-24-oic acid |
| HSD-542-IS | [1,2-13C2, 2,2-2H2,3-15N]glycine conjugate of 3β-sulfooxy-7α,12α-dihydroxy-chol-5-en-24-oic acid |
| AKR-444 | Glycine conjugate of 3-oxo-7α-hydroxy-chol-4-en-24-oic acid |
| AKR-460 | Glycine conjugate of 3-oxo-7α,12α-dihydroxy-chol-4-en-24-oic acid |
| AKR-494 | Taurine conjugate of 3-oxo-7α-hydroxy-chol-4-en-24-oic acid |
| AKR-510 | Taurine conjugate of 3-oxo-7α,12α-dihydroxy-chol-4-en-24-oic acid |
| AKR-444-IS | [1,2-13C2, 2,2-2H2,3-15N]glycine conjugate of 3-oxo-7α-hydroxy-chol-4-en-24-oic acid |
| AKR-460-IS | [1,2-13C2, 2,2-2H2,3-15N]glycine conjugate of 3-oxo-7α,12α-dihydroxy-chol-4-en-24-oic acid |
| AKR-494-IS | [1,1,2,2-2H4]taurine conjugate of 3-oxo-7α-hydroxy-chol-4-en-24-oic acid |
| AKR-510-IS | [1,1,2,2-2H4]taurine of 3-oxo-7α,12α-dihydroxy-chol-4-en-24-oic acid |
| CYP7-453 | 3β-sulfooxy-chol-5-en-24-oic acid |
| CYP7-510 | Glycine conjugate of 3β-sulfooxy-chol-5-en-24-oic acid |
| CYP7-453-IS | [2,3,3,23,23-2H5]3β-sulfooxy-chol-5-en-24-oic acid |
| CYP7-510-IS | [1,2-13C2,2,2-2H2, 3-15N]glycine conjugate of 3β-sulfooxy-chol-5-en-24-oic acid |
| CTX-611 | 5β-cholestane-3α,7α,12α, 25-tetrol-3-O-β-glucuronide |
| CTX-627 | 5β-cholestane-3α,7α,12α, 23S, 25-pentol-23-O-β-glucuronide |
| CTX-611-IS | [25,25,25,26,26,26-2H6]5β-cholestane-3α,7α,12α, 25-tetrol-3-O-β-glucuronide |